Harmony Biosciences Holdings names new director
23 November 2021 -

Harmony Biosciences Holdings Inc. (Nasdaq: HRMY), a United States-based commercial stage pharmaceutical company, announced on Monday that it has named Linda Szyper as its new director.

Szyper has over 30 years of experience that includes both pharmaceutical sales and marketing and healthcare communications services. She held the position of chief operating officer at McCann Health. She has also served as chief commercial officer of Circassia and chief development officer of Publicis healthcare Communications Group. She held roles of varying scopes and responsibilities at other life sciences and pharmaceutical companies, including Searle and Serono Laboratories.

Szyper holds a Bachelor of Science in Biomedical Engineering from Northwestern University and Master of Business Administration from DePaul University.